Biocept : Bankruptcy - Form 8-K

Item 1.03Bankruptcy or Receivership.

After considering strategic alternatives, Biocept, Inc., a Delaware corporation (the "Company"), filed a voluntary petition for relief (the "Petition") under the provisions of Chapter 7 of Title 11 of the United States Code, 11 U.S.C. §§ 101 et seq. (the "Code") in the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on October 13, 2023.

The proceeding under the Petition is styled as "In Re: Biocept, Inc." As a result of filing the Petition, a Chapter 7 trustee will be appointed by the Bankruptcy Court to administer the bankruptcy estate of the Company and to perform the duties set forth in Section 704 of the Code. The assets of the Company will be liquidated and any claims paid in accordance with the Code.